Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

BenevolentBio brings AI-powered discovery to human health and bioscience. It operates as a BenevolentAI subsidiary focused on disease areas like inflammation, neurodegeneration, orphan diseases, and…

BenevolentBio brings AI-powered discovery to human health and bioscience. It operates as a BenevolentAI subsidiary focused on disease areas like inflammation, neurodegeneration, orphan diseases, and…
What they do: AI-powered drug discovery and biomedical research as the BenevolentAI subsidiary focused on human health
Therapeutic focus: Neurodegeneration (ALS, Parkinson's, Alzheimer's), inflammation, rare/orphan diseases, some cancers
Customers / model: B2B SaaS for pharmaceutical and biotech R&D teams
Founded: 2013
Drug discovery and biomedical research acceleration for complex diseases.
2013
Biotechnology
$115M
Funding round raised by parent BenevolentAI in April 2018; reported valuation ~$2B. BenevolentBio is identified as a subsidiary of BenevolentAI.
“Includes investors associated with the BenevolentAI group such as Woodford Investment Management and other family offices/strategic backers”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week